Response

Affiliations

¹ Pancreaticobiliary Medicine Unit, University College London Hospitals, London, UK; First Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, Macedonia, Greece.
² Gastroenterology and Hepatology, University of Utah Health, Salt Lake City, Utah, USA.
³ Department of Gastroenterology, General Hospital of Nea Ionia "Konstantopoulio-Patision", Athens, Greece; Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology, Erasme University Hospital, Brussels, Belgium.

Apostolis Papaefthymiou et al. Gastrointest Endosc. 2023 Nov.

. 2023 Nov;98(5):875-876.

doi: 10.1016/j.gie.2023.06.006.

¹ Pancreaticobiliary Medicine Unit, University College London Hospitals, London, UK; First Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, Macedonia, Greece.
² Gastroenterology and Hepatology, University of Utah Health, Salt Lake City, Utah, USA.
³ Department of Gastroenterology, General Hospital of Nea Ionia "Konstantopoulio-Patision", Athens, Greece; Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology, Erasme University Hospital, Brussels, Belgium.

No abstract available

Publication types